Next Article in Journal
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study
Next Article in Special Issue
Intronic Polyadenylation in Acquired Cancer Drug Resistance Circumvented by Utilizing CRISPR/Cas9 with Homology-Directed Repair: The Tale of Human DNA Topoisomerase IIα
Previous Article in Journal
Elevated MACC1 Expression in Colorectal Cancer Is Driven by Chromosomal Instability and Is Associated with Molecular Subtype and Worse Patient Survival
Previous Article in Special Issue
Alternative Splicing in Cancer and Immune Cells
 
 
Review

Article Versions Notes

Cancers 2022, 14(7), 1750; https://doi.org/10.3390/cancers14071750
Action Date Notes Link
article xml file uploaded 30 March 2022 06:21 CEST Original file -
article xml uploaded. 30 March 2022 06:21 CEST Update https://www.mdpi.com/2072-6694/14/7/1750/xml
article pdf uploaded. 30 March 2022 06:21 CEST Version of Record https://www.mdpi.com/2072-6694/14/7/1750/pdf
article html file updated 30 March 2022 06:22 CEST Original file -
article html file updated 2 August 2022 16:22 CEST Update https://www.mdpi.com/2072-6694/14/7/1750/html
Back to TopTop